Business Wire

CA-NETAPP

7.5.2024 14:01:35 CEST | Business Wire | Press release

Share
New Market Research Finds Up to 20% of AI Initiatives Fail Without Intelligent Data Infrastructure

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today unveiled insights from its latest report on the evolving landscape of AI in the enterprise. The IDC White Paper, sponsored by NetApp, “Scaling AI Initiatives Responsibly: The Critical Role of an Intelligent Data Infrastructure*,” reveals the various challenges and business benefits at different levels of AI maturity and provides insights into the successful strategies adopted by leading organizations in their efforts to responsibly scale AI and GenAI workloads. By spotlighting actionable approaches, the report aims to help organizations avoid common pitfalls, ensuring that their AI initiatives are not one of the 20% that are likely to fail. The report also introduces a detailed AI maturity model developed to assess organizational progress based on their approach to AI, from AI Emergents and AI Pioneers, to AI Leaders and AI Masters

Intelligent Data Infrastructure is the Foundation of AI Success

The IDC White Paper found that:

  • AI Masters optimize their data infrastructure for transformational AI initiatives by facilitating easy access to corporate datasets with minimal preparation and designing a unified, hybrid, multicloud environment that supports various data types and access methods.
  • AI Masters have more ambitious AI goals and yet experience data-related failures including infrastructure-based data access limitations (21%), compliance limitations (16%), and insufficient data (17%).
  • AI Emergents note similar challenges but also experience budget constraints (20% Emergents vs 9% AI Masters), insufficient data for model training (26% vs 17%) and business restrictions on data access (28% vs 20%).

According to the findings, organizations need an intelligent data infrastructure in order to scale AI initiatives responsibly. Where a company falls on the AI maturity scale is determined by the level of infrastructure they have in place that will not only drive the long-term success of AI projects, but also of their associated business outcomes. Those organizations that are just beginning or have recently begun their AI journey typically have disparate data architectures or plans for a more unified architecture, while AI Leaders and AI Masters are likely already executing on a unified vision. As a result, organizations with the most AI experience are failing less.

“This IDC White Paper further solidifies that companies need intelligent data infrastructure to scale AI responsibly and boost the rate of AI initiative success,” said Jonsi Stefansson, Senior Vice President and Chief Technology Officer at NetApp. “With intelligent data infrastructure in place, companies have the flexibility to access any data, anywhere with integrated data management to ensure data security, protection, and governance and adaptive operations that can optimize performance, cost and sustainability.”

Data Infrastructure Flexibility is Crucial for Data Access and AI Initiative Success

The IDC White Paper found that:

  • 48% of AI Masters report they have instant availability of their structured data and 43% of their unstructured data, while AI Emergents have only 26% and 20% respectively.
  • AI Masters (65%) and AI Emergents (35%) reported their current data architectures can seamlessly integrate their organization’s private data with AI Cloud services.

According to the research, AI Masters know that their data architecture and infrastructure for transformational AI initiatives must offer ease of access to corporate data sets without any—or with only minor—preparation or preprocessing.

“Infrastructure decisions made during the design and planning process of AI Initiatives must factor in architecture flexibility,” said Ritu Jyoti Group Vice President, Worldwide Artificial Intelligence and Automation Research Practice, Global AI Research Lead, at IDC. “The dynamic nature of data inputs to AI and GenAI workstreams means easy access to distributed and diverse data—both structured and unstructured data sets with varying characteristics—is critical. This requires a flexible, unified approach to storage, a common control plane, and management tools that make it seamless for data scientists and developers to consume data with MLOps integrations.”

Effective Data Governance and Security Processes Drive AI Success

The IDC White Paper found that:

  • The inability for AI Emergents to progress is often due to a lack of standardized governance policies and procedures; only 8% of AI Emergents have completed and standardized these across all AI projects, compared to 38% of AI Masters.
  • While 51% of AI Masters reported they have standardized policies in place that are rigorously enforced by an independent group in their organization, only 3% of AI Emergents claim this.

The study found that effective data governance and security are crucial indicators of organizational maturity in AI initiatives. Managing data responsibly and securely remains a key issue for enterprises, because AI stakeholders often try to shortcut security processes to accelerate development. Feedback from organizations that have become more successful at delivering positive outcomes from their AI initiatives demonstrates that governance and security are not merely cost centers but vital enablers of innovation. By prioritizing security, data sovereignty, and regulatory compliance, organizations can mitigate risk in their AI and GenAI initiatives and ensure that their data engineers and scientists can focus on maximizing efficiency and productivity.

Efficient Use of Resources Important for Scaling AI Responsibly

The IDC White Paper found that:

  • 43% of AI Masters have clearly defined metrics for assessing resource efficiency when developing AI models that were completed and standardized across all AI projects compared to 9% of AI Emergents.
  • 63% of all respondents reported the need for major improvements or a complete overhaul to ensure their storage is optimized for AI and only 14% indicated they needed no improvements.

As AI workflows become increasingly integral to almost every industry, it’s critical to acknowledge the impact on compute and storage infrastructure, data and energy resources, and their associated costs. A key measure of AI maturity is the definition and implementation of metrics to assess the efficiency of resource use in the creation of AI models.

Methodology

In December of 2023 and January of 2024, IDC conducted 24 in-depth interviews and 1,220 quantitative interviews by web survey with global decision makers involved in IT operations, data science, data engineering and software development related to AI initiatives. These interviews revealed in-depth information about the state of AI initiatives today including the array of challenges, numerous business benefits, and best practices that leading organizations have taken to achieve success.

In conducting this analysis IDC has developed an AI maturity model where organizations fall into one of four maturity levels based on their current approach to AI in terms of data and storage infrastructure, data policy and governance, resource efficiency focus, and stakeholder enablement and collaboration. These maturity levels are AI Emergents, AI Pioneers, AI Leaders, and AI Masters.

*Source: IDC White Paper sponsored by NetApp, "Scaling AI Initiatives Responsibly: The Critical Role of an Intelligent Data Infrastructure," Doc #US52048524, April 2024

Learn more at: https://www.netapp.com/pdf.html?item=/media/107000-wp-scaling-ai-initiatives.pdf

Join NetApp and a guest speaker from IDC on Wednesday, May 22 at 11am ET for the “Scaling AI Initiatives Responsibly: The Critical Role of an Intelligent Data Infrastructure” Webcast: https://www.netapp.com/forms/ai-thought-leadership-webinar/

About NetApp

NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability, and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

Additional Resources

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507078248/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release

-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release

A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper

Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release

Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user

Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release

Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye